Photo from archive.org
We thank Eduardo Urdaneta, from Merck & Co., Inc., for his correspondence regarding our paper [1] and appreciate the opportunity to reply to his concern. Click to show full abstract
We thank Eduardo Urdaneta, from Merck & Co., Inc., for his correspondence regarding our paper [1] and appreciate the opportunity to reply to his concern.
Keywords:
children initiated;
drug reactions;
reactions children;
initiated montelukast;
neuropsychiatric adverse;
adverse drug
Journal Title: European Respiratory Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: European Respiratory Journal
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!